UBS Group’s FT Vest US Equity Enhance & Moderate Buffer ETF October XOCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$45.2K Buy
1,145
+206
+22% +$8.02K ﹤0.01% 7626
2026
Q1
$35K Buy
939
+553
+143% +$20.9K ﹤0.01% 7595
2025
Q4
$14.6K Buy
386
+319
+476% +$11.9K ﹤0.01% 7993
2025
Q3
$2.47K Buy
+67
New +$2.43K ﹤0.01% 9168
2025
Q2
Sell
-628
Closed -$21.3K 10902
2025
Q1
$21.3K Buy
+628
New +$21.6K ﹤0.01% 8193
2024
Q4
Sell
-6,149
Closed -$208K 10482
2024
Q3
$208K Buy
6,149
+4,517
+277% +$152K ﹤0.01% 5846
2024
Q2
$54.5K Buy
1,632
+1,568
+2,450% +$51.8K ﹤0.01% 6625
2024
Q1
$2.1K Buy
64
+40
+167% +$1.3K ﹤0.01% 7981
2023
Q4
$767 Buy
+24
New +$751 ﹤0.01% 8523

Other funds holding XOCT

UBS Group's XOCT Position: Q2 2026 in Review

UBS Group increased its FT Vest US Equity Enhance & Moderate Buffer ETF October (XOCT) stake by 22% in Q2 2026, buying an estimated $8.02K and bringing the position to 1,145 shares worth $45.2K. The position accounts for ﹤0.01% of the portfolio, ranked #7626.

UBS Group first reported a position in XOCT in Q4 2023 and has held it in 9 quarters since. The position peaked at $208K in Q3 2024. 43 funds tracked by Wall St. Rank hold XOCT as of Q2 2026.

  • UBS Group held 1,145 shares of FT Vest US Equity Enhance & Moderate Buffer ETF October worth $45.2K as of Q2 2026.
  • UBS Group bought 206 FT Vest US Equity Enhance & Moderate Buffer ETF October shares in Q2 2026, an estimated $8.02K.
  • FT Vest US Equity Enhance & Moderate Buffer ETF October made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #7626 holding.
  • UBS Group first reported a position in FT Vest US Equity Enhance & Moderate Buffer ETF October in Q4 2023 and has held it in 9 quarters since.
  • UBS Group's FT Vest US Equity Enhance & Moderate Buffer ETF October position peaked at $208K in Q3 2024.
  • 43 funds tracked by Wall St. Rank held FT Vest US Equity Enhance & Moderate Buffer ETF October as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.